EG15009A - Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds - Google Patents

Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds

Info

Publication number
EG15009A
EG15009A EG80174A EG17480A EG15009A EG 15009 A EG15009 A EG 15009A EG 80174 A EG80174 A EG 80174A EG 17480 A EG17480 A EG 17480A EG 15009 A EG15009 A EG 15009A
Authority
EG
Egypt
Prior art keywords
antisecretory
esters
amino
preparing
quinolinecarboxylic acids
Prior art date
Application number
EG80174A
Other languages
English (en)
Inventor
Randal Harry
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Application granted granted Critical
Publication of EG15009A publication Critical patent/EG15009A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG80174A 1979-03-26 1980-03-25 Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds EG15009A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
EG15009A true EG15009A (en) 1985-03-31

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
EG80174A EG15009A (en) 1979-03-26 1980-03-25 Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds

Country Status (31)

Country Link
US (1) US4343804A (forum.php)
JP (1) JPH02117663A (forum.php)
AR (1) AR230268A1 (forum.php)
AT (1) AT372373B (forum.php)
AU (1) AU528388B2 (forum.php)
BR (1) BR8001779A (forum.php)
CA (1) CA1147338A (forum.php)
CH (1) CH644105A5 (forum.php)
DE (1) DE3011490A1 (forum.php)
DK (1) DK156056C (forum.php)
EG (1) EG15009A (forum.php)
ES (1) ES8103048A1 (forum.php)
FI (1) FI77452C (forum.php)
FR (1) FR2452485B1 (forum.php)
GB (1) GB2047244B (forum.php)
GR (1) GR68006B (forum.php)
HK (1) HK67983A (forum.php)
IE (1) IE49577B1 (forum.php)
IL (1) IL59628A (forum.php)
IN (1) IN151446B (forum.php)
IT (1) IT1133079B (forum.php)
MX (1) MX6264E (forum.php)
NL (1) NL8001752A (forum.php)
NO (1) NO153927C (forum.php)
NZ (1) NZ193252A (forum.php)
PH (1) PH16416A (forum.php)
PL (1) PL125030B1 (forum.php)
PT (1) PT71008B (forum.php)
SE (1) SE435837B (forum.php)
SG (1) SG33683G (forum.php)
YU (1) YU41702B (forum.php)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
AU682051B2 (en) * 1993-08-10 1997-09-18 James Black Foundation Limited Gastrin and CCK receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
BR9914164A (pt) 1998-09-29 2001-06-26 American Cyanamid Co Composto, método para o tratamento, inibição do crescimento de, ou erradiacação de um neoplasma, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e, processo para preparar um composto
EP1243583B1 (en) * 1999-12-28 2005-09-28 Eisai Co., Ltd. Heterocyclic compounds having sulfonamide groups
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
JP4742026B2 (ja) 2003-03-10 2011-08-10 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストの新規の製造方法
EP2287166A3 (en) * 2003-07-14 2011-06-22 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
US8853419B2 (en) 2010-01-27 2014-10-07 Arena Pharmaceuticals, Inc. Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
JP5941916B2 (ja) 2010-09-22 2016-06-29 アリーナ ファーマシューティカルズ, インコーポレイテッド Gpr119レセプターのモジュレーターおよびそれに関連する障害の処置
PT3242666T (pt) 2015-01-06 2024-12-09 Arena Pharm Inc Composto para utilização no tratamento de patologias relacionadas com o recetor s1p1
US10301262B2 (en) 2015-06-22 2019-05-28 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
DK3538512T3 (da) * 2016-11-11 2021-07-05 Bayer Animal Health Gmbh Nye anthelmintiske quinolin-3-carboxamid-derivater
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
WO2019084271A1 (en) * 2017-10-25 2019-05-02 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE
AU2019266511B2 (en) 2018-05-09 2022-12-08 Elanco Animal Health Gmbh New quinoline derivatives
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (forum.php) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
DK128380A (da) 1980-09-27
FI800910A7 (fi) 1980-09-27
ES489887A0 (es) 1981-02-16
SE435837B (sv) 1984-10-22
NL8001752A (nl) 1980-09-30
HK67983A (en) 1983-12-23
AU528388B2 (en) 1983-04-28
JPH02117663A (ja) 1990-05-02
IT1133079B (it) 1986-07-09
AT372373B (de) 1983-09-26
BR8001779A (pt) 1980-11-18
AU5684880A (en) 1980-10-02
IN151446B (forum.php) 1983-04-23
YU41702B (en) 1987-12-31
PT71008A (en) 1980-04-01
FR2452485B1 (fr) 1986-09-12
ATA156480A (de) 1983-02-15
GR68006B (forum.php) 1981-10-26
DK156056B (da) 1989-06-19
NO153927C (no) 1986-06-18
ES8103048A1 (es) 1981-02-16
MX6264E (es) 1985-02-19
IL59628A0 (en) 1980-06-30
DK156056C (da) 1989-11-06
CA1147338A (en) 1983-05-31
IE49577B1 (en) 1985-10-30
FR2452485A1 (fr) 1980-10-24
DE3011490A1 (de) 1981-03-12
YU84480A (en) 1983-10-31
CH644105A5 (fr) 1984-07-13
GB2047244A (en) 1980-11-26
SG33683G (en) 1985-03-29
GB2047244B (en) 1983-02-23
US4343804A (en) 1982-08-10
PL125030B1 (en) 1983-03-31
NZ193252A (en) 1984-04-27
FI77452B (fi) 1988-11-30
PT71008B (en) 1981-06-25
FI77452C (fi) 1989-03-10
IE800605L (en) 1980-09-26
PH16416A (en) 1983-09-29
DE3011490C2 (forum.php) 1988-12-22
SE8002292L (sv) 1980-09-27
NO800858L (no) 1980-09-29
PL222993A1 (forum.php) 1981-01-30
IT8067465A0 (it) 1980-03-26
NO153927B (no) 1986-03-10
AR230268A1 (es) 1984-03-01
IL59628A (en) 1983-06-15

Similar Documents

Publication Publication Date Title
EG15009A (en) Process for preparing 4-amino-3-quinolinecarboxylic acids and esters-antisecretory;anti-ulcer compounds
PT69172A (en) Process for preparing 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
PT72241B (en) Process for preparing cyclo-octapeptides
GB2066245B (en) Process for preparing hydroxyalkylaminosulphonic acids
GB2042531B (en) Process for preparing d- -amino acids
PT70927A (en) Process for preparing 9-aminoalkylfluorenes
YU48279A (en) Process for preparing insecticidic and acaricidic compounds
DE3266120D1 (en) Process for preparing amino-arylsulphonic acids
DE3061037D1 (en) Process for preparing dimethylaminosilanes
YU245080A (en) Process for preparing 1-amino-3-benzene-phenylacetamides
GB2073736B (en) Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
ZA804198B (en) Novel ergol-8-ene and ergolin compounds and process for preparing same
DE3264098D1 (en) Process for preparing 1-alkyl-2-chloro-5-nitro-benzene-4-sulphonic acids
DE3060089D1 (en) Process for preparing 1-amino-2-phenoxy-4-hydroxy-anthraquinone
DE3260577D1 (en) Process for preparing s-aryl-thioglycolic acids
PT71126A (en) Process for preparing alkoxyalkylidenhydrazinopyridazines
GB2058068B (en) Process for preparing 5-chloro-2-nitrophenol
HU178840B (en) Process for preparing 6-chloro-alpha-methyl-carbazol-2-acetic acid
GB2023585B (en) 1-pyrrole - and 1-pyrrolidine-carboxylic acid derivatives and process for preparing the same
DE3060850D1 (en) Process for preparing naphthalenesulphochloride
YU182480A (en) Process for obtaining alpha-aryl-propionic acids
ZA794245B (en) N-phenethylacetamide compounds and process for preparation thereof
CU35107A (en) Sulphonilureas process for preparing it and compounds thereof
DE3064662D1 (en) Process for the preparation of 5-oxo-alkanoic acids
YU39849B (en) Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds